Abe M - Search Results

1

Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells.

Nakano A, Tsuji D, Miki H, Cui Q, El Sayed SM, Ikegame A, Oda A, Amou H, Nakamura S, Harada T, Fujii S, Kagawa K, Takeuchi K, Sakai A, Ozaki S, Okano K, Nakamura T, Itoh K, Matsumoto T, Abe M. Nakano A, et al. Among authors: abe m. PLoS One. 2011;6(11):e27222. doi: 10.1371/journal.pone.0027222. Epub 2011 Nov 2. PLoS One. 2011. PMID: 22073292 Free PMC article.

2

Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells.

Abe M, Shintani Y, Eto Y, Harada K, Kosaka M, Matsumoto T. Abe M, et al. J Leukoc Biol. 2002 Aug;72(2):347-52. J Leukoc Biol. 2002. PMID: 12149426

3

Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma.

Abe M, Hiura K, Wilde J, Moriyama K, Hashimoto T, Ozaki S, Wakatsuki S, Kosaka M, Kido S, Inoue D, Matsumoto T. Abe M, et al. Blood. 2002 Sep 15;100(6):2195-202. Blood. 2002. PMID: 12200385 Free article.

4

Primary adult T-cell leukemia/lymphoma of bone.

Hara T, Wakatsuki S, Ozaki S, Abe M, Kosaka M. Hara T, et al. Among authors: abe m. Int J Hematol. 2004 Feb;79(2):157-60. doi: 10.1532/ijh97.03006. Int J Hematol. 2004. PMID: 15005344

5

Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myeloma.

Hashimoto T, Abe M, Oshima T, Shibata H, Ozaki S, Inoue D, Matsumoto T. Hashimoto T, et al. Among authors: abe m. Br J Haematol. 2004 Apr;125(1):38-41. doi: 10.1111/j.1365-2141.2004.04864.x. Br J Haematol. 2004. PMID: 15015966 Free article.

6

Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion.

Abe M, Hiura K, Wilde J, Shioyasono A, Moriyama K, Hashimoto T, Kido S, Oshima T, Shibata H, Ozaki S, Inoue D, Matsumoto T. Abe M, et al. Blood. 2004 Oct 15;104(8):2484-91. doi: 10.1182/blood-2003-11-3839. Epub 2004 Jun 8. Blood. 2004. PMID: 15187021 Free article.

7

[Biochemical markers in bone metastasis].

Hashimoto T, Abe M, Matsumoto T. Hashimoto T, et al. Among authors: abe m. Gan To Kagaku Ryoho. 2004 Jul;31(7):1027-33. Gan To Kagaku Ryoho. 2004. PMID: 15272580 Review. Japanese.

8

[Successful treatment of relapsed/refractory Hodgkin's lymphoma with tandem transplantation].

Shichijo K, Sekimoto E, Mihara A, Ohta K, Tanaka Y, Ohshima T, Shibata H, Hashimoto T, Ozaki S, Abe M, Matsumoto T, Wakatsuki S. Shichijo K, et al. Among authors: abe m. Nihon Naika Gakkai Zasshi. 2004 Oct 10;93(10):2210-2. doi: 10.2169/naika.93.2210. Nihon Naika Gakkai Zasshi. 2004. PMID: 15552924 Japanese. No abstract available.

9

2D7 diabody bound to the alpha2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells.

Kimura N, Kawai S, Kinoshita Y, Ishiguro T, Azuma Y, Ozaki S, Abe M, Sugimoto M, Hirata Y, Orita T, Okabe H, Matsumoto T, Tsuchiya M. Kimura N, et al. Among authors: abe m. Biochem Biophys Res Commun. 2004 Dec 24;325(4):1201-9. doi: 10.1016/j.bbrc.2004.10.163. Biochem Biophys Res Commun. 2004. PMID: 15555554

10

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.

Oshima T, Abe M, Asano J, Hara T, Kitazoe K, Sekimoto E, Tanaka Y, Shibata H, Hashimoto T, Ozaki S, Kido S, Inoue D, Matsumoto T. Oshima T, et al. Among authors: abe m. Blood. 2005 Nov 1;106(9):3160-5. doi: 10.1182/blood-2004-12-4940. Epub 2005 Jul 19. Blood. 2005. PMID: 16030194 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,211 results

Search Page

Filters